Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Allosteric Modulation of Muscarinic Acetylcholine ReceptorsJan Jakubík, Esam E El-FakahanyBiomolecules|February 23, 2020
Current Advances in Allosteric Modulation of Muscarinic ReceptorsJan Jakubik, Esam E El-FakahanyInternational Journal of Molecular Sciences|March 6, 2021
Allosteric Modulation of GPCRs of Class A by CholesterolJan Jakubík, Esam E El-FakahanyEuropean Journal of Pharmacology|February 9, 2002
Microglial derived nitric oxide decreases serotonin content in rat basophilic leukemia (RBL-2H3) cellsDavid R Linden, Esam E El-FakahanyNeurochemical Research|August 30, 2002
Arachidonic acid inhibition of muscarinic receptor-mediated nitric oxide production occurs at the level of calcium mobilization in Chinese hamster ovary cellsDavid R Linden, Esam E el-FakahanyBrain Research. Molecular Brain Research|April 20, 2005
Mechanisms of M(1) muscarinic receptor-mediated up-regulation of neuronal nitric oxide synthase in N1E-115 neuroblastoma cellsAdolfo E Cuadra, Esam E El-FakahanyThe Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptorJan Jakubík, Stanislav Tucek, Esam E El-FakahanyNeurochemical Research|May 14, 2014
Changes in Membrane Cholesterol Differentially Influence Preferential and Non-preferential Signaling of the M1 and M3 Muscarinic Acetylcholine ReceptorsPavel Michal, Esam E El-Fakahany, Vladimír DoležalLife Sciences|January 27, 2004
Therapeutic interventions targeting the nitric oxide system: current and potential uses in obstetrics, bone disease and erectile dysfunctionMarianne K O Grant, Esam E El-FakahanyThe Journal of Pharmacology and Experimental Therapeutics|July 9, 2005
Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptorMarianne K O Grant, Esam E El-FakahanyPageof 4